(Q35461651)

8 August 2017

title

The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes: a phase-III intergroup study (English)

1 reference

8 August 2017

1 reference

K. B. Miller

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1420504

24 September 2022

K. Kim

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1420504

24 September 2022

F. S. Morrison

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1420504

24 September 2022

J. N. Winter

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1420504

24 September 2022

J. M. Bennett

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1420504

24 September 2022

R. S. Neiman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1420504

24 September 2022

D. R. Head

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1420504

24 September 2022

P. A. Cassileth

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1420504

24 September 2022

M. J. O'Connell

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1420504

24 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1420504

24 September 2022

publication date

1 October 1992

1 reference

8 August 2017

1 reference

8 August 2017

volume

65

1 reference

8 August 2017

issue

4

1 reference

8 August 2017

page(s)

162-168

1 reference

Bone marrow transplantation for patients with myelodysplasia. Pretreatment variables and outcome

8 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01703109

Proposals for the classification of the myelodysplastic syndromes

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01703109

Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01703109

Response of preleukemic syndromes to continuous infusion of low-dose cytarabine

21 January 2018

1 reference

12 December 2020

Randomized study of 13-cis retinoic acid v placebo in the myelodysplastic disorders

1 reference

12 December 2020

Effects of recombinant human interleukin-3 in patients with myelodysplastic syndromes

1 reference

12 December 2020

A critical appraisal of low-dose cytosine arabinoside in patients with acute non-lymphocytic leukemia and myelodysplastic syndromes

1 reference

12 December 2020

The myelodysplastic syndromes: biology and implications for management

1 reference

12 December 2020

Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndrome

1 reference

12 December 2020

Induction of differentiation of human myeloid leukemia cells by inhibitors of DNA synthesis.

1 reference

12 December 2020

Effect of chemotherapy for the dysmyelopoietic syndrome

1 reference

12 December 2020

Prognostic factors in chronic myelodysplastic syndromes: a multivariate analysis in 107 cases.

1 reference

12 December 2020

High-dose cytosine arabinoside in the treatment of preleukemic disorders: a leukemia intergroup study

1 reference

12 December 2020

Chronic myelodysplastic syndrome: short survival with or without evolution to acute leukaemia

1 reference

12 December 2020

Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes

1 reference

12 December 2020

Myelodysplastic syndromes: analysis of clinical and prognostic features in 96 patients

1 reference

12 December 2020

Evaluation of survival data and two new rank order statistics arising in its consideration

1 reference

12 December 2020

Alpha-interferon in myelodysplasia; clinical observations and effects on NK cells

1 reference

12 December 2020

Aggressive chemotherapy in adult primary myelodysplastic syndromes. A report on 29 cases

1 reference

12 December 2020

Low-dose cytosine arabinoside (Ara-C) therapy in the myelodysplastic syndromes and acute leukemia

1 reference

12 December 2020

The role of aggressive chemotherapy in the treatment of the myelodysplastic syndromes

1 reference

12 December 2020

Refined chromosome analysis as an independent prognostic indicator in de novo myelodysplastic syndromes

1 reference

12 December 2020

Utility of the FAB classification for myelodysplastic syndromes: investigation of prognostic factors in 237 cases

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01703109

1 reference

8 August 2017

1 reference